0001181431-12-049082.txt : 20120906
0001181431-12-049082.hdr.sgml : 20120906
20120906175119
ACCESSION NUMBER: 0001181431-12-049082
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120905
FILED AS OF DATE: 20120906
DATE AS OF CHANGE: 20120906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDO DALE G
CENTRAL INDEX KEY: 0001202278
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 121077830
MAIL ADDRESS:
STREET 1: C/O CELL GENESYS INC
STREET 2: 500 FORBES BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
4
1
rrd355320.xml
FORM 4
X0306
4
2012-09-05
0
0001001233
SANGAMO BIOSCIENCES INC
SGMO
0001202278
ANDO DALE G
C/O SANGAMO BIOSCIENCES INC.
POINT RICHMOND TECH CNTR, 501 CANAL BLVD
RICHMOND
CA
94804
0
1
0
0
VP, Therapeutic Dev. & CMO
Common Stock
2012-09-05
4
M
0
15000
3.61
A
83534
D
Common Stock
2012-09-05
4
S
0
15000
5.60
D
68534
D
Employee Stock Option (Right to Buy)
3.61
2012-09-05
4
M
0
15000
0
D
2014-08-01
Common Stock
15000
80800
D
The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2012.
All shares underlying this option are vested and immediately exercisable.
/s/ Dale G. Ando
2012-09-06